Summit Therapeutics Plc Ord 1P is listed on the London Stock Exchange trading with ticker code SUMM.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £4,250m, with approximately 160m shares in issue.
Summit Therapeutics Plc is in the Medicine and Biotech Research sector.
|Eckoh Plc (ECK.L)|
|Tungsten Corporation Plc (TUNG.L)|
|Oxford Biomedica Plc (OXB.L)|
|Michelmersh Brick Holdings Plc (MBH.L)|
|Horizon Discovery Group Plc (HZD.L)|
|Shares in Issue||160m|
|52 Week High||0.00|
|52 Week Low||0.00|